Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

43%

3 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
2(66.7%)
Phase 4
1(33.3%)
3Total
Phase 3(2)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT04881838Phase 3Active Not Recruiting

CCCG-ALCL-2020 for Chinese Children and Adolescents With Newly Diagnosed High-risk ALCL

Role: collaborator

NCT07288749Phase 3Not Yet Recruiting

Efficacy Evaluation of Glimepiride in Patients With Type 2 Diabetes Mellitus and Chronic Heart Failure With Reduced Ejection Fraction.

Role: collaborator

NCT04926038Unknown

Descriptive and Risk Factors Analysis of All-cause Postoperative Death in Patients Undergoing Emergency Surgery

Role: collaborator

NCT04926025Unknown

Descriptive and Risk Factors Analysis of All-cause Postoperative Death in Patients Undergoing Prolonged Surgery

Role: collaborator

NCT04929886Unknown

Descriptive and Risk Factors Analysis of All-cause Postoperative Death in Patients Undergoing Elective Surgery

Role: collaborator

NCT04926012Unknown

Descriptive and Risk Factors Analysis of All-cause Postoperative Death in Patients Undergoing Cardiovascular Surgery

Role: collaborator

NCT01883180Phase 4Completed

ATG in Haploidentical HSCT for Acute Graft-versus-host Disease Prophylaxis

Role: collaborator

All 7 trials loaded